Update on mucosal immunoglobulin A in gastrointestinal disease

Current Opinion in Gastroenterology

Volumn 26, Issue 6, 2010, Pages 554-563

  Brandtzaeg, Per ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

celiac disease; epithelial barrier; food allergy; gastritis; inflammatory bowel disease

Indexed keywords

ANTIGEN; GLUTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SECRETORY IMMUNOGLOBULIN;

ANTIBODY RESPONSE; BACTEROIDES THETAIOTAOMICRON; CELIAC DISEASE; COMMENSAL; DERMATITIS HERPETIFORMIS; ENTERITIS; FOOD ALLERGY; GASTRITIS; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HOMEOSTASIS; HOST PATHOGEN INTERACTION; INTESTINE EPITHELIUM; LAMINA PROPRIA; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PLASMA CELL; REVIEW;

ANIMALS; CELIAC DISEASE; FOOD HYPERSENSITIVITY; GASTRITIS; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PLASMA CELLS;

EID: 77958469091     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32833dccf8     Document Type: Review

References (100)

1. Brandtzaeg P, Johansen F-E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005; 206:32-63.
2. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009; 70:505-515.
3. Corthesy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol 2010; 5:817-829.
4. Mantis NJ, Forbes SJ. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest 2010; 39:383-406.
5. Brandtzaeg P. Functions of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest 2010; 39:303-355.
6. Brandtzaeg P, Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 1984; 311:71-73.
7. Johansen F-E, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol 2001; 167:5185-5192.
8. Braathen R, Hohman VS, Brandtzaeg P, Johansen F-E. Secretory antibody formation: conserved binding interactions between J chain and polymeric Ig receptor from humans and amphibians. J Immunol 2007; 178:1589-1597.
9. Persson CG, Erjefalt JS, Greiff L, et al. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol 1998; 47:302-313.
10. Bouvet JP, Pires R, Iscaki S, et al. Nonimmune macromolecular complexes of Ig in human gut lumen. Probable enhancement of antibody functions. J Immunol 1993; 151:2562-2571.
11. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Faba fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 1989; 19:2243-2249.
12. Brandtzaeg P. Mechanisms of gastrointestinal reactions to food. Environ Toxicol Pharmacol 1997; 4:9-24.
13. Mazanec MB, Nedrud JG, Kaetzel CS, et al. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993; 14:430-435.
14. Robinson JK, Blanchard TG, Levine AD, et al. A mucosal IgA-mediated excretory immune system in vivo. J Immunol 2001; 166:3688-3692.
15. Burns JW, Siadat-Pajouh M, Krishnaney AA, et al. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996; 272:104-107.
16. Brandtzaeg P, Baklien K, Bjerke K, et al. Nature and properties of the human gastrointestinal immune system. In: Miller K, Nicklin S, editors. Immunology of the gastrointestinal tract, vol. I. Boca Raton, Florida, USA: CRC Press; 1987. pp. 1-85.
17. Wolf HM, Fischer MB, Puhringer H, et al. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-a, interleukin-6) in human monocytes. Blood 1994; 83:1278-1288.
18. Smith PD, Smythies LE, Mosteller-Barnum M, et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS-and IgA-mediated activities. J Immunol 2001; 167:2651-2656.
19. Hamre R, Farstad IN, Brandtzaeg P, Morton HC. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand J Immunol 2003; 57:506-516.
20. Wolf HM, Vogel E, Fischer MB, et al. Inhibition of receptor-dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum IgA. Pediatr Res 1994; 36:235-243.
21. Deviere J, Vaerman JP, Content J, et al. IgA triggers tumor necrosis factor a secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis. Hepatology 1991; 13:670-675.
22. Lamkhioued B, Gounni AS, Gruart V, et al. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995; 25:117-125.
23. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998; 161:4340-4346.
24. Rugtveit J, Bakka A, Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) co-stimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 1997; 110:104-113.
25. Hausmann M, KiesslingS, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002; 122:1987-2000.
26. van Elburg RM, Uil JJ, de Monchy JG, Heymans HS. Intestinal permeability in pediatric gastroenterology. Scand J Gastroenterol Suppl 1992; 194:19-24.
27. Johansen F-E, Pekna M, Norderhaug IN, et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med 1999; 190:915-921.
28. Sait LC, Galic M, Price JD, et al. Secretory antibodies reduce systemic antibody responses against the gastrointestinal commensal flora. Int Immunol 2007; 19:257-265.
29. Karlsson MR, Johansen FE, Kahu H, et al. Hypersensitivity and oral tolerance in the absence of a secretory immune system. Allergy 2010; 65:561-570.
30. Janzi M, Kull I, Sjoberg R, et al. Selective IgA deficiency in early life: association to infections and allergic diseases during childhood. Clin Im munol 2009; 133:78-85.
31. Brandtzaeg P. Impact of immunodeficiency on immunological homeostasis in the gut. In: Lukas M, Manns MP, Spicák J, Stange EF, editors. Immunological diseases of liver and gut. Falk Symposium 135. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2004. pp. 180-209.
32. Murthy AK, Dubose CN, Banas JA, et al. Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis. J Gastroenterol Hepatol 2006; 21:1372-1380.
33. Fagarasan S, Muramatsu M, Suzuki K, et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002; 298:1424-1427.
34. Carlsen HS, Baekkevold ES, Johansen F-E, et al. Bcell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 2002; 51:364-371.
35. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136:65-80.
36. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-521.
37. Feng T, Wang L, Schoeb TR, et al. Microbiota innate stimulation is a prerequisite forTcell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010; 207:1321-1332.
38. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-323.
39. Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007; 2:328-339.
40. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, et al. The key role of seg-mented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31:677-689.
41. Ivanov II, Littman DR. Segmented filamentous bacteria take the stage. Mucosal Immunol 2010; 3:209-212.
42. ObataT, Goto Y, Kunisawa J, et al. Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci USA 2010; 107:7419-7424.
43. Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease. Adv Exp Med Biol 2006; 579:149-167.
44. Brandtzaeg P. The changing immunological paradigm in coeliac disease. Immunol Lett 2006; 105:127-139.
45. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002; 37:1034-1041.
46. Kett K, Rognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 1987; 93:919-924.
47. Helgeland L, Tysk C, Jarnerot G, et al. The IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut 1992; 33:1358-1364.
48. Brandtzaeg P, Korsrud FR. Significance of different J-chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J-chain expressing capacity of the total local immunocyte population, including IgG-and IgD-producing cells, and depends on the clinical state of the tissue. Clin Exp Immunol 1984; 58:709-718.
49. Kett K, Brandtzaeg P. Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon. Gut 1987; 28:1013-1021.
50. Kett K, Brandtzaeg P, Fausa O. J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease. Gastroenterology 1988; 94:1419-1425.
51. Van Den Bogaerde J, Cahill J, Emmanuel AV, et al. Gut mucosal response to food antigens in Crohn's disease. Aliment Pharmacol Ther 2002; 16:1903-1915.
52. Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996; 38:365-375.
53. Foo MC, Lee A. Immunological response of mice to members of the autochthonous intestinal microflora. Infect Immun 1972; 6:525-532.
54. Berg RD, Savage DC. Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms. Infect Immun 1975; 11: 320-329.
55. Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun 1995; 63:3904-3913.
56. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102:448-455.
57. Duchmann R, Neurath MF, Meyer zum Buschenfelde KH. Responses to self and nonself intestinal microflora in health and inflammatory bowel disease. Res Immunol 1997; 148:589-594.
58. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617-620.
59. van der Waaij LA, Limburg PC, Mesander G, van der Waaij D. In vivo IgA coating of anaerobic bacteria in human faeces. Gut 1996; 38:348-354.
60. van der Waaij LA, Kroese FGM, Jansen PLM, et al. IBD patients have a very high percentage of colonic anaerobic bacteria that are in vivo coated with IgA, IgGorIgM, irrespective of clinical activity. Gut 1997; 41 (Suppl3):A117.
61. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto-and microbial antigens. Gastroenterology 2002; 123:689-699.
62. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
63. Smithson JE, Radford-Smith G, Jewell GP. Appendectomy and tonsillectomy in patients with inflammatory bowel disease. J Clin Gastroenterol 1995; 21:283-286.
64. Mitchell SA, Thyssen M, Orchard TR, et al. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 2002; 51:567-573.
65. Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344:808-814.
66. Beaugerie L, Sokol H. Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. Inflamm Bowel Dis 2010; 16:356-357.
67. Bjerke K, Brandtzaeg P, Rognum TO. Distribution of immunoglobulin producing cells is different in normal human appendix and colon mucosa. Gut 1986; 27:667-674.
68. Bjerke K, Brandtzaeg P. Terminally differentiated human intestinal B cells. J chain expression of IgA and IgG subclass-producing immunocytes in the distal ileum compared with mesenteric and peripheral lymph nodes. Clin Exp Immunol 1990; 82:411-415.
69. Bjerke K, Brandtzaeg P. Immunoglobulin-and J chain-producing cells associated with lymphoid follicles in the human appendix, colon and ileum, including Peyer's patches. Clin Exp Immunol 1986; 64:432-441.
70. Mizoguchi A, Mizoguchi E, Chiba C, et al. Role of appendix in the development of inflammatory bowel disease in TCR-a mutant mice. J Exp Med 1996; 184:707-715.
71. Krieglstein CF, Cerwinka WH, Laroux FS, et al. Role of appendix and spleen in experimental colitis. J Surg Res 2001; 101:166-175.
72. Smart CJ, Calabrese A, Oakes DJ, et al. Expression of the LFA-1 beta 2 integrin (CD11a/CD18) and ICAM-1 (CD54) in normal and coeliac small bowel mucosa. Scand J Immunol 1991; 34:299-305.
73. Lycke N, Kilander A, Nilsson LA, et al. Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level. Gut 1989; 30:72-77.
74. Brandtzaeg P, Halstensen TS, Huitfeldt HS, et al. Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann N Y Acad Sci 1992; 664:157-179.
75. Lavo B, Knutson F, Knutson L, et al. Jejunal secretion of secretory immunoglobulins and gliadin antibodies in celiac disease. Dig Dis Sci 1992; 37:53-59.
76. Colombel JF, Mascart-Lemone F, Nemeth J, et al. Jejunal immunoglobulin and antigliadin antibody secretion in adult coeliac disease. Gut 1990; 31:1345-1349.
77. O'Mahony S, Arranz E, Barton JR, Ferguson A. Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut 1991; 32:29-35.
78. Labrooy JT, Hohmann AW, Davidson GP, et al. Intestinal and serum antibody in coeliac disease: a comparison using ELISA. Clin Exp Immunol 1986; 66:661-668.
79. Kett K, Scott H, Fausa O, Brandtzaeg P. Secretory immunity in celiac disease: cellular expression of immunoglobulin A subclass and joining chain. Gastroenterology 1990; 99:386-392.
80. Hansson T, Dannaeus A, Kraaz W, et al. Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up. Pediatr Res 1997; 41:554-559.
81. Osman AA, Richter T, Stern M, Mothes T. The IgA subclass distributions of endomysium and gliadin antibodies in human sera are different. Clin Chim Acta 1996; 255:145-152.
82. Picarelli A, Maiuri L, Frate A, et al. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 1996; 348:1065-1067.
83. Picarelli A, Sabbatella L, Di Tola M, et al. Antiendomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus. Clin Exp Immunol 2005; 142:111-115.
84. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797-801.
85. Schuppan D, Dieterich W, Riecken EO. Exposing gliadin as a tasty food for lymphocytes. Nat Med 1998; 4:666-667.
86. Korponay-Szabo IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53:641-648.
87. Salmi TT, Collin P, Jarvinen O, et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006; 24:541-552.
88. Tosco A, Maglio M, Paparo F, et al. Immunoglobulin A antitissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr 2008; 47:293-298.
89. Matysiak-BudnikT, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferring receptor in celiac disease. J Exp Med 2008; 205:143-154.
90. Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010; 3:247-259.
91. Mazumdar K, Alvarez X, Borda JT, et al. Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques. PLoS One 2010; 5:e10228.
92. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin. Gastroenterology 1984; 86:402-412.
93. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy. Gut 1986; 27:505-514.
94. Valnes K, Brandtzaeg P, Elgjo K, et al. Local immunoglobulin production is different in gastritis associated with dermatitis herpetiformis and simple gastritis. Gut 1987; 28:1589-1594.
95. Berstad AE, Kilian M, Valnes KN, Brandtzaeg P. Increased mucosal production of monomeric IgA1 but no IgA1 protease activity in Helicobacter pylori gastritis. Am J Pathol 1999; 155:1097-1104.
96. Berstad AE, Brandtzaeg P, Stave R, Halstensen TS. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 1997; 40:196-203.
97. Hansson M, Hermansson M, Svensson H, et al. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect Immun 2008; 76:3304-3311.
98. Kiriya K, Watanabe N, Nishio A, et al. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis. Int Immunol 2007; 19:435-446.
99. Latcham F, Merino F, Lang A, et al. A consistent pattern of minor immunodeficiency and subtle enteropathy in children with multiple food allergy. J Pediatr 2003; 143:39-47.
100. Brandtzaeg P. Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol 2010; 7:380-400.